Profusa, Inc. Common Stock vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| PFSA | SYK | |
|---|---|---|
| Market Cap | $228,059 | $130.11 billion |
| Revenue (TTM) | — | $25.84 billion |
| Net Income (TTM) | $-36,563,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| PFSA | SYK | |
|---|---|---|
| P/E Ratio | — | 34.37 |
| Price / Book | -0.01 | 5.42 |
| Price / Sales | — | 5.04 |
PFSA leads on 1 of 1 valuation factors.
Profitability
| PFSA | SYK | |
|---|---|---|
| Net Margin | — | 14.43% |
| Return on Equity | 129.67% | 15.55% |
PFSA leads on 1 of 1 profitability factors.
Dividend
| PFSA | SYK | |
|---|---|---|
| Dividend Yield | — | 1.06% |
| Payout Ratio | — | 36.48 |
PFSA and SYK split the dividend factors evenly.
Risk & Sentiment
| PFSA | SYK | |
|---|---|---|
| Short Interest | 7.30% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: PFSA overview, PFSA financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.